Get the app!
Back to Trades
Other3

AVANOS MEDICAL, INC.

AVNS

Total Value
$NaN

Company Information

Ticker Symbol
AVNS
CIK
0001606498

Insider Information

Role
SVP, Chief Financial Officer
Officer
Location
ALPHARETTA, GA

Filing Details

Filing Date
Aug 22, 2025
Transaction Date
Aug 1, 2025
Accession Number
0001606498-25-000114
Form Type
3

Footnotes

  1. (F1)Of these shares, 80,718 are represented by unvested time-based restricted share units (TRSUs) awarded pursuant to the Issuer's 2021 Long Term Incentive Plan, as amended. These TRSUs will vest as follows: (i) 7,821 on March 6, 2026; (ii) 3,235 on March 7, 2026; (iii) 12,225 on April 22, 2026; (iv) 13,661 on August 1, 2026; (v) 5,330 on March 6, 2027; (vi) 3,236 on March 7, 2027; (vii) 13,661 on August 1, 2027; (viii) 3,334 on March 7, 2028; and (ix) 18,215 on August 1, 2028. Each TRSU is the economic equivalent of one share of Common Stock.
  2. (F2)These options vested 30% on May 5, 2017, 30% on May 5, 2018, and 40% on May 5, 2019.
  3. (F3)These options vested 30% on May 3, 2018, 30% on May 3, 2019, and 40% on May 3, 2020.
  4. (F4)These options vested 30% on May 3, 2019, 30% on May 3, 2020, and 40% on May 3, 2021.
  5. (F5)These options vested 30% on May 8, 2020, 30% on May 8, 2021, and 40% on May 8, 2022.
  6. (F6)These options vested 30% on May 7, 2021, 30% on May 7, 2022, and 40% on May 7, 2023.
  7. (F7)These options will vest 30% on March 7, 2026, 30% on March 7, 2027 and 40% on March 7, 2028.

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.